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CDC continues to work with the World Health Organization 
(WHO) and other partners to closely monitor Middle East 
respiratory syndrome coronavirus (MERS-CoV) infections 
globally and to better understand the risks to public health. The 
purpose of this report is to provide a brief update on MERS-
CoV epidemiology and to notify health care providers, public 
health officials, and others to maintain awareness of the need 
to consider MERS-CoV infection in persons who have recently 
traveled from countries in or near the Arabian Peninsula.*
MERS-CoV was first identified and reported to WHO 
in September 2012 (1). As of January 23, 2015, WHO has 
confirmed 956 laboratory-confirmed† cases of MERS-CoV 
infection, which include at least 351 deaths. All reported 
cases have been directly or indirectly linked through travel or 
residence to nine countries: Saudi Arabia, the United Arab 
Emirates, Qatar, Jordan, Oman, Kuwait, Yemen, Lebanon, 
and Iran. In the United States, two patients tested positive for 
MERS-CoV in May 2014, each of whom had a history of fever 
and one or more respiratory symptoms after recent travel from 
Saudi Arabia (2). No further cases have been reported in the 
United States despite nationwide surveillance and the testing 
of 514 patients from 45 states to date.
The majority (504) of the 956 MERS cases were reported 
to have occurred during March–May 2014 (Figure). However, 
WHO continues to receive reports of MERS cases, mostly from 
Saudi Arabia.§ From August 1, 2014, through January 23, 
2015, WHO confirmed 102 cases, 97 of which occurred in 
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FIGURE.  Number of cases of Middle East respiratory syndrome coronavirus infection reported by the World Health Organization,* by month 
of illness onset — worldwide, 2012–2015
* Data as of January 23, 2015, available at http://www.who.int/csr/don/archive/disease/coronavirus_infections/en.
† During June 3–October 16, 2014, a total of 130 additional cases and 84 deaths were reported with insufficient information to determine month of onset. These cases 
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* Countries considered in the Arabian Peninsula and neighboring include: 
Bahrain; Iraq; Iran; Israel, the West Bank and Gaza; Jordan; Kuwait; Lebanon; 
Oman; Qatar; Saudi Arabia; Syria; the United Arab Emirates; and Yemen.
† Confirmatory laboratory testing requires a positive polymerase chain reaction 
test result on at least two specific genomic targets for MERS-CoV or a single 
positive target with sequencing on a second.
§ Additional information available at http://www.who.int/csr/don/archive/
disease/coronavirus_infections/en.
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persons with residence in Saudi Arabia, including three travel-
associated cases reported by Austria, Turkey, and Jordan; of the 
remaining cases, two cases were in persons from Qatar, and 
three cases were in persons from Oman.
CDC continues to recommend that U.S. travelers to coun-
tries in or near the Arabian Peninsula protect themselves from 
respiratory diseases, including MERS, by washing their hands 
often and avoiding contact with persons who are ill. If travelers 
to the region have onset of fever and symptoms of respiratory 
illness during their trip or within 14 days of returning to the 
United States, they should seek medical care. They should call 
ahead to inform their health care provider of their recent travel 
so that appropriate isolation measures can be taken in health 
care settings. Health care providers and health departments 
throughout the United States should continue to consider a 
diagnosis of MERS-CoV infection in persons who develop 
fever and respiratory symptoms within 14 days after travel-
ing from countries in or near the Arabian Peninsula, and be 
prepared to detect and manage cases of MERS.
Recommendations might change and be updated as addi-
tional data become available. More detailed travel recom-
mendations related to MERS, including general precautions 
posted by WHO for anyone visiting farms, markets, barns, 
or other places where animals are present, are available at 
http://wwwnc.cdc.gov/travel/notices/alert/coronavirus-
arabian-peninsula. The website also lists more specific WHO 
recommendations for persons with diabetes, kidney failure, 
or chronic lung disease, and immunocompromised persons, 
that include avoiding contact with camels.¶ Guidance on the 
evaluation of patients for MERS-CoV infection, infection 
control, home care and isolation, and clinical specimen col-
lection and testing is available on the CDC MERS website at 
http://www.cdc.gov/coronavirus/mers/index.html. Treatment 
is supportive; no specific treatment for MERS-CoV infection is 
available. WHO has posted guidance for clinical management 
of MERS patients at http://www.who.int/csr/disease/coro-
navirus_infections/InterimGuidance_ClinicalManagement_
NovelCoronavirus_11Feb13u.pdf?ua=1.
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